Skip to main content

Advertisement

SpringerLink
Log in

Association between retinol binding protein 4 and diabetic retinopathy among type 2 diabetic patients: a meta-analysis

  • Original Article
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

Abstract

Aims

The aim of this study was to investigate the association between retinol-binding protein 4 (RBP4) and diabetic retinopathy (DR) among patients with type 2 diabetes mellitus (T2DM).

Methods

Databases PubMed, Embase, Web of Science, Chinese National Knowledge Infrastructure, VIP, and Wangfang were searched to July 30, 2019. The Newcastle–Ottawa Scale was applied to assess the quality of all identified studies, and those qualified were included in the meta-analysis. The Chi squared Q test and I2 statistics were conducted to evaluate heterogeneity. Standardized mean differences (SMD) and 95% confidence intervals (CI) among RBP4 within the DR and T2DM without retinopathy (DWR) groups were pooled using the random effects model depending on the heterogeneity. Subgroup analyses were conducted among the groups having different diabetes duration, detection methods, body mass index, and total cholesterol and triglyceride levels. The funnel plot was used to assess publication bias.

Results

Nineteen observational studies were included in our meta-analysis. RBP4 was significantly higher in both nonproliferative DR (SMD: 0.72, 95% CI 0.48–0.95, P < 0.00001) and proliferative DR (SMD: 2.68, 95% CI 1.69–3.67, P < 0.00001) groups despite high heterogeneity (I2 = 87 and 97% in DR and PDR groups, respectively). Significant differences were noted among most subgroups (P < 0.05). Among those accompanied by hypercholesterolemia, the association between RBP4 and DR were unclear (P = 0.09).

Conclusions

Elevated RBP4 is strongly associated with DR and may play an essential role in its progression. Additional large-scale controlled studies are needed to confirm these findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Cheung N, Mitchell P, Wong TY (2010) Diabetic retinopathy. Lancet 376(9735):244–252

    Article  Google Scholar 

  2. Whiting DR, Guariguata L, Weil L, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94(3):311–321

    Article  PubMed  Google Scholar 

  3. Ting DS, Cheung GC, Wong TY (2016) Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol 44(4):260–277

    Article  PubMed  Google Scholar 

  4. Antonetti DA, Barber AJ, Bronson SK, Freeman WM, Gardner TW, Jefferson LS et al (2006) Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 55(9):2401–2411

    Article  CAS  PubMed  Google Scholar 

  5. Curtis TM, Gardiner TA, Stitt AW (2009) Microvascular lesions of diabetic retinopathy: Clues towards understanding pathogenesis? Eye 23(7):1496–1508

    Article  CAS  PubMed  Google Scholar 

  6. Dong J, Wong TY (2012) Current epidemiology of diabetic retinopathy and diabetic macular edema. Curr Diab Rep 12(4):346–354

    Article  Google Scholar 

  7. Kappelgaard P, Holfort SK, Klefter ON, Larsen M (2018) Retinal vessel diameter changes in relation to dark adaptation and acute hyperglycemia. J Ophthalmol 2018:7064359

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Afrashi F, Erakgün T, Köse S, Ardiç K, Menteş J (2003) Blue-on-yellow perimetry versus achromatic perimetry in type 1 diabetes patients without retinopathy. Diabetes Res Clin Pract 61(1):7–11

    Article  PubMed  Google Scholar 

  9. Wolff BE, Bearse MA, Schneck ME, Dhamdhere K, Harrison WW, Barez S et al (2015) Color vision and neuroretinal function in diabetes. Doc Ophthalmol 130(2):131–139

    Article  CAS  PubMed  Google Scholar 

  10. Tawfik A, Mohamed R, Elsherbiny NM, DeAngelis MM, Bartoli M, Al-Shabrawey M (2019) Homocysteine: a potential biomarker for diabetic retinopathy. J Clin Med 8(1):E121

    Article  PubMed  CAS  Google Scholar 

  11. Malecki MT, Undas A, Cyganek K, Mirkiewicz-Sieradzka B, Wolkow P, Osmenda G et al (2007) Plasma asymmetric dimethylarginine (ADMA) is associated with retinopathy in type 2 diabetes. Diabetes Care 30(11):2899–2901

    Article  PubMed  Google Scholar 

  12. Reddy VS, Sethi S, Agrawal P, Gupta N, Garg R (2015) Ischemia modified albumin (IMA) and albumin adjusted-IMA (AAIMA) as biomarkers for diabetic retinopathy. Nepal J Ophthalmol 7(14):117–123

    PubMed  Google Scholar 

  13. Rodríguez AJ, Nunes Vdos S, Mastronardi CA, Neeman T, Paz-Filho GJ (2016) Association between circulating adipocytokine concentrations and microvascular complications in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of controlled cross-sectional studies. J Diabetes Complicat 30(2):357–367

    Article  Google Scholar 

  14. Chen H, Zhang X, Liao N, Wen F (2016) Increased levels of IL-6, sIL-6R, and sgp130 in the aqueous humor and serum of patients with diabetic retinopathy. Mol Vis 22:1005–1014

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Palanisamy K, Raman R, Sulochana KN, Chidambaram S (2019) Adiponectin: a potential candidate for treating fibrosis in posterior segment of the eye. Med Hypotheses 123:9–12

    Article  CAS  PubMed  Google Scholar 

  16. Majerczyk M, Kocełak P, Choręza P, Arabzada H, Owczarek AJ, Bożentowicz-Wikarek M et al (2018) Components of metabolic syndrome in relation to plasma levels of retinol binding protein 4 (RBP4) in a cohort of people aged 65 years and older. J Endocrinol Invest 41(10):1211–1219

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Borodkina DA, Gruzdeva OV, Belik EV, Palicheva EI, Kuzmina AA (2018) The perspectives of application of retinol-binding protein as a biomarker of risk of cardiovascular pathology. Klin Lab Diagn 63(2):79–84

    CAS  PubMed  Google Scholar 

  18. Quadro L, Blaner WS, Salchow DJ, Vogel S, Piantedosi R, Gouras P et al (1999) Impaired retinal function and vitamin A availability in mice lacking retinolbinding protein. EBO J 18(17):4633–4644

    CAS  Google Scholar 

  19. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM et al (2005) Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436(7049):356–362

    Article  CAS  PubMed  Google Scholar 

  20. Li ZZ, Lu XZ, Liu JB, Chen L (2010) Serum retinol-binding protein 4 levels in patients with diabetic retinopathy. J Int Med Res 38(1):95–99

    Article  PubMed  Google Scholar 

  21. Takebayashi K, Suetsugu M, Wakabayashi S, Aso Y, Inukai T (2007) Retinol binding protein-4 levels and clinical features of type 2 diabetes patients. J Clin Endocrinol Metab 92(7):2712–2719

    Article  CAS  PubMed  Google Scholar 

  22. Li JY, Chen XX, Lu XH, Zhang CB, Shi QP, Feng L (2018) Elevated RBP4 plasma levels were associated with diabetic retinopathy in type 2 diabetes. Biosci Rep 38(5):BSR20181100

    Article  PubMed  PubMed Central  Google Scholar 

  23. Stang A (2010) Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605

    Article  PubMed  Google Scholar 

  24. Zhao L, Wu C, Zhao J (2016) Change of serum RBP4 level in patients with diabetic retinopathy combined with subclinical hypothyroidism and its influence on diabetic retinopathy. Chin Gen Pract 19(8):903–907 (Chinese)

    Google Scholar 

  25. Zhao LJ, Wang W (2013) Association of serum retinol binding protein 4 with diabetic retinopathy in type 2 diabetes mellitus. J Southeast Univ (Med Sci Ed) 32(3):266–269 (Chinese)

    CAS  Google Scholar 

  26. Gao Y, Huang Q, Liu LT, Wang YQ (2015) Correlation between retinol binding protein 4 and type 2 diabetic retinopathy. Zhejiang Jo Integr Tradit Chinese West Med 25(5):489–490 (Chinese)

    Google Scholar 

  27. Tian T, Ma XH, Shen J (2011) Association of serum lipoprotein (a) level, retinol-binding protein 4 with diabetic retinopathy in type 2 diabetes. Acta Univ Med Nanjing (Nat Scie) 31(11):1620–1622+1652 (Chinese)

    CAS  Google Scholar 

  28. Liang D (2012) Study on factors influencing type 2 diabetic retinopathy. Hebei Medical University, Shijiazhuang (Chinese)

    Google Scholar 

  29. Jiang FS (2009) The meaning of serum retinal binding protein 4 in studying diabetic retinopathy in type 2 diabetes. Suzhou Univ J Med Sci (Chinese)

  30. Yin Q, Guo SQ, Zhang YL, Wang H, Xiao YX, Wang J et al (2016) Relationship of serum RBP4 and neutrophil- lymphocyte ratio with type 2 diabetic retinopathy. Chin J Mod Med 26(6):54–58 (Chinese)

    Google Scholar 

  31. Jiang F, Li YM, Deng B, Chen LL (2013) The correlation between diabetic retinopathy and serum retinol binding protein 4 in type 2 diabetes. J Trop Med 13(9):1075–1077, 1094 (Chinese)

    CAS  Google Scholar 

  32. Wang LJ, Wang DQ, Zhou YH, Han XJ, Yuan XL, Qian J (2018) Changes and significance of serum retinol binding protein 4 and cystatin C levels in patients with diabetic retinopathy. Chin Gen Pract 21(5):517–520, 525 (Chinese)

    Google Scholar 

  33. Wang XJ (2018) The relationship between serum retinol binding protein 4 and diabetic retinopathy in type 2 diabetes. Guangxi Medical University, Nanning (Chinese)

    Google Scholar 

  34. Li PW (2018) Clinical study on the relationship between serum retinol binding protein 4 and type 2 diabetic retinopathy. Zhengzhou University, Zhengzhou (Chinese)

    Google Scholar 

  35. Bao T, Pan HF, Qi Y, Hao L (2018) Value of combined detection of serum markers in early diabetic retinopathy using ROC curve. Contemp Med 24(29):38–41 (Chinese)

    Google Scholar 

  36. Huang LL, Yu J, Zhou SX, Wang L, Peng Y, Liu XL et al (2016) Correlation analysis of Hcy and RBP4 with diabetic retinopathy. Rec Adv Ophthal 36(3):244–246 (Chinese)

    CAS  Google Scholar 

  37. Zhou HY, Yue XL, Shi JH (2013) The correlative study of serum retinol-binding protein 4 and diabetic retinopathy of elderly type 2 diabetic patient. J Bengbu Med Coll 7(38):803–808 (Chinese)

    Google Scholar 

  38. Yao JP, Li SB, Zheng SY, Qiu W (2015) Relationship between serum retinol binding protein 4 and diabetic retinopathy. Zhejiang Med J 37(12):1058–1060 (Chinese)

    CAS  Google Scholar 

  39. Xu SH, Liu J, Yang XT, Jing L, Lin SD, Wu D et al (2017) Correlation between type 2 diabetic retinopathy and serum retinol 4 levels. Diabetes New Word 20(18):161–162 (Chinese)

    Google Scholar 

  40. Zheng Y, He M, Congdon N (2012) The worldwide epidemic of diabetic retinopathy. Indian J Ophthalmol 60(5):428–431

    Article  PubMed  PubMed Central  Google Scholar 

  41. Sasongko MB, Wardhana FS, Febryanto GA, Agni AN, Supanji S, Indrayanti SR (2020) The estimated healthcare cost of diabetic retinopathy in Indonesia and its projection for 2025. Br J Ophthalmol 104:487–492

    Article  PubMed  Google Scholar 

  42. Kern TS (2007) Contributions of inlammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res 2007(2007):95103

    PubMed  PubMed Central  Google Scholar 

  43. Tang J, Kern TS (2011) Inflammation in diabetic retinopathy. Prog Retin Eye Res 30(5):343–358

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Nalini M, Raghavulu BV, Annapurna A, Avinash P, Chandi V, Swathi N et al (2017) Correlation of various serum biomarkers with the severity of diabetic retinopathy. Diabetes Metab Syndr 11:S451–S454

    Article  PubMed  Google Scholar 

  45. Akbay E, Muslu N, Nayir E, Ozhan O, Kiykim A (2010) Serum retinol binding protein 4 level is related with renal functions in Type 2 diabetes. J Endocrinol Invest 33(10):725–729

    Article  CAS  PubMed  Google Scholar 

  46. Malechka VV, Moiseyev G, Takahashi Y, Shin Y, Ma JX (2017) Impaired rhodopsin generation in the rat model of diabetic retinopathy. Am J Pathol 187(10):2222–2231

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Racz B, Petrukhin K (2017) Effect of the advanced non-retinoid RBP4 antagonist on vascular permeability in the mouse diabetic retinopathy model. Investig Ophthalmol Vis Sci 58(8):5799

    Google Scholar 

  48. Farjo KM, Farjo RA, Halsey S, Moiseyev G, Ma JX (2012) Retinol-binding protein 4 induces inflammation in human endothelial cells by an NADPH oxidase- and nuclear factor kappa B-dependent and retinol-independent mechanism. Mol Cell Biol 32(24):5103–5115

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Moraes-Vieira PM, Yore MM, Dwyer PM, Syed I, Aryal P, Kahn BB (2014) RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistance. Cell Metab 19(3):512–526

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Hummasti S, Hotamisligil GS (2010) Endoplasmic reticulum stress and inflammation in obesity and diabetes. Circ Res 107(5):579–591

    Article  CAS  PubMed  Google Scholar 

  51. Wei Y, Xia N, Zhang W, Huang J, Ren Z, Zhu L et al (2019) Serum retinol-binding protein 4 is associated with insulin resistance in patients with early and untreated rheumatoid arthritis. Joint Bone Spine 86(3):335–341

    Article  CAS  PubMed  Google Scholar 

  52. Soprano DR, Soprano KJ, Goodman DS (1986) Retinol-binding protein messenger RNA levels in the liver and in extrahepatic tissues of the rat. J Lipid Res 27(2):166–171

    Article  CAS  PubMed  Google Scholar 

  53. Park SE, Kim DH, Lee JH, Park JS, Kang ES, Ahn CW et al (2009) Retinol-binding protein-4 is associated with endothelial dysfunction in adults with newly diagnosed type 2 diabetes mellitus. Atherosclerosis 204(1):23–25

    Article  CAS  PubMed  Google Scholar 

  54. Du M, Martin A, Hays F, Johnson J, Farjo RA, Farjo KM (2017) Serum retinol-binding protein-induced endothelial inflammation is mediated through the activation of toll-like receptor 4. Mol Vis 23(2):185–197

    CAS  PubMed  PubMed Central  Google Scholar 

  55. Du M, Otalora L, Martin AA, Moiseyev G, Vanlandingham P, Wang Q et al (2015) Transgenic mice overexpressing serum retinol-binding protein develop progressive retinal degeneration through a retinoid-independent mechanism. Mol Cell Biol 35(16):2771–2789

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Rostamkhani H, Mellati AA, Tabaei BS, Alavi M, Mousavi SN (2019) Association of serum zinc and vitamin a levels with severity of retinopathy in type 2 diabetic patients: a cross-sectional study. Biol Trace Elem Res 92(2):123–128

    Article  CAS  Google Scholar 

  57. Zhang C, Li K, Zhang J, Kuang X, Liu C, Deng Q et al (2019) Relationship between retinol and risk of diabetic retinopathy: a case-control study. Asia Pac J Clin Nutr 28(3):607–613

    PubMed  Google Scholar 

  58. Voigt M, Schmidt S, Lehmann T, Köhler B, Kloos C, Voigt UA et al (2018) Prevalence and progression rate of diabetic retinopathy in type 2 diabetes patients in correlation with the duration of diabetes. Exp Clin Endocrinol Diabetes 126(9):570–576

    Article  CAS  PubMed  Google Scholar 

  59. Qi Q, Yu Z, Ye X, Zhao F, Huang P, Hu FB et al (2007) Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. J Clin Endocrinol Metab 92(12):4827–4834

    Article  CAS  PubMed  Google Scholar 

  60. Wang W, Li N (2015) Correlation of retinol binding protein 4 with metabolic indexes of glucose and lipid, bile cholesterol saturation index. Zhong Nan Da Xue Xue Bao Yi Xue Ban 40(6):657–665 (Chinese)

    CAS  PubMed  Google Scholar 

  61. Hu S, Liu Q, Huang X, Tan H (2016) Serum level and polymorphisms of retinol-binding protein-4 and risk for gestational diabetes mellitus: a meta-analysis. BMC Pregnancy Childbirth 16(1):1–11

    Article  CAS  Google Scholar 

  62. Zhu YY, Zhang JL, Liu L, Han Y, Ge X, Zhao S (2018) Evaluation of serum retinol-binding protein-4 levels as a biomarker of poor short-term prognosis in ischemic stroke. Biosci Rep 38(5):1–11

    Article  CAS  Google Scholar 

  63. Tu WJ, Zeng XW, Deng A, Zhao SJ, Luo DZ, Ma GZ et al (2017) Circulating FABP4 (fatty acid-binding protein 4) Is a novel prognostic biomarker in patients with acute ischemic Stroke. Stroke 48(6):1531–1538

    Article  CAS  PubMed  Google Scholar 

  64. Toruner F, Altinova AE, Akturk M, Kaya M, Arslan E, Bukan N et al (2011) The relationship between adipocyte fatty acid binding protein-4, retinol binding protein-4 levels and early diabetic nephropathy in patients with type 2 diabetes. Diabetes Res Clin Pract 91(2):203–207

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the grant from National Key R&D Program of China (2018YFC1314900, 2018YFC1314902), Nantong “226 Project”, Excellent Key Teachers in the “Qing Lan Project” of Jiangsu Colleges and Universities, Jiangsu Students’ Platform for innovation and entrepreneurship training program (201910304108Y) and Jiangsu postgraduate research and innovation program (KYCX19_2070).

Author information

Author notes

  1. Wentao Han and Huagen Wei have contributed equally to this work.

Authors and Affiliations

  1. Department of Medical Informatics, Medical School of Nantong University, Nantong, 226001, People’s Republic of China

    Wentao Han, Huagen Wei, Weizheng Kong, Jing Wang, Luqian Yang & Huiqun Wu

Authors
  1. Wentao Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Huagen Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Weizheng Kong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jing Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Luqian Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Huiqun Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Huiqun Wu.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest.

Ethical standard

All the procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration.

Informed consent

For this type of study formal consent is not required.

Additional information

This article belongs to the topical collection Eye Complications of Diabetes, managed by Giuseppe Querques.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Han, W., Wei, H., Kong, W. et al. Association between retinol binding protein 4 and diabetic retinopathy among type 2 diabetic patients: a meta-analysis. Acta Diabetol 57, 1203–1218 (2020). https://doi.org/10.1007/s00592-020-01535-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-020-01535-3

Keywords

Search

Navigation